by Jason Heaviland | Nov 6, 2025 | Uncategorized
How Quality Infrastructure Impacts Scientific Impact The scientific landscape has shifted dramatically as reproducibility concerns have fundamentally changed how reviewers evaluate manuscripts, how funding agencies assess proposals, and how collaborators choose...
by Jason Heaviland | Nov 5, 2025 | Uncategorized
Radioligand therapy (RLT) has emerged as a transformative precision oncology approach with remarkable initial response rates. However, treatment resistance remains a critical challenge that can limit long-term therapeutic success. Imaging technologies—including PET,...
by Jason Heaviland | Nov 4, 2025 | Uncategorized
The Metabolic Frontier of Neuroscience: Lessons from Alzheimer’s Disease Alzheimer’s disease is a complex, devastating neurodegenerative disorder and the most common form of dementia, affecting millions globally. While decades of research have focused on the infamous...
by Jason Heaviland | Nov 3, 2025 | Uncategorized
The comprehensive evaluation of natural product therapeutic efficacy requires sophisticated analytical approaches that extend beyond traditional single-endpoint assessments to encompass dynamic host response profiling through integrated metabolomics and proteomics...
by Jason Heaviland | Oct 1, 2025 | Uncategorized
Why Cancer Vaccine Mechanism of Action Requires All Three ‘Omics Your IND submission for an mRNA cancer vaccine needs a mechanism of action section. You have data showing mRNA delivery, antigen expression, and tumor response. But can you demonstrate the complete...
